Teva Stops Production At US Plant After FDA Concerns: Report
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has temporarily stopped drug production at its Irvine plant in California to address issues raised by…
Teva Reaches Agreement With Louisiana To Settle State’s Opioid-Related Claims
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Louisiana that settles the state's opioid-related
Teva, MedinCell Announce FDA Acceptance Of New Drug Application For TV-46000/mdc-IRM As A Treatment For Patients With Schizophrenia
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia
File acceptance marks important milestone for Teva's commitment to treatments
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining.
Teva Reports Post Hoc Analysis Of Long-Term Data Examining Treatment With AUSTEDO Tablets In Adult Patients With Tardive Dyskinesia
Findings Published in The American Journal of Geriatric Psychiatry
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Understanding Teva Pharmaceutical Indus’s Unusual Options Activity
On Tuesday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $9.96.
10 Health Care Stocks Showing Unusual Options Activity In Today’s Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.